Acurable develops wearable medical devices able to accurately diagnose and manage respiratory conditions at home.
Acurable has raised $10.8M in total funding. The most recent round was Series A. The last funding was announced in October 2022.
Acurable's investors include Kindred Capital, Kibo Ventures, Alma Mundi Ventures, Innovate UK, Meridian Health Ventures.
Acurable is headquartered in London, United Kingdom.
Acurable develops wearable medical devices able to accurately diagnose and manage respiratory conditions at home.
Acurable is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Acurable — Funding & Investors." VCBacked, October 3, 2022, https://www.vcbacked.co/company/acurable. Accessed August 13, 2026.
VCBacked. (2022). Acurable — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/acurable
{{cite web |title=Acurable — Funding & Investors |url=https://www.vcbacked.co/company/acurable |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated